Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical Schoolpost, shared a post on X:
“Impressive snapshot of drug availability by public vs private system for treating breast cancer in Brazil.
Most targeted drugs, including ADCs, are only covered by private insurance, leading to dramatic differences in outcomes. Great presentation by Gustavo Werutsky at JBCS 2026.”
Other articles featuring Paolo Tarantino on OncoDaily.